- Home
- SLNO vs MQ Comparison
SLNO vs MQ Comparison
Compare SLNO & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- MQ
- Stock Information
- Founded
- SLNO 1999
- MQ 2010
- Country
- SLNO United States
- MQ United States
- Employees
- SLNO N/A
- MQ N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MQ Computer Software: Prepackaged Software
- Sector
- SLNO Health Care
- MQ Technology
- Exchange
- SLNO Nasdaq
- MQ Nasdaq
- Market Cap
- SLNO 2.2B
- MQ 1.9B
- IPO Year
- SLNO 2014
- MQ 2021
- Fundamental
- Price
- SLNO $46.13
- MQ $3.69
- Analyst Decision
- SLNO Strong Buy
- MQ Hold
- Analyst Count
- SLNO 5
- MQ 15
- Target Price
- SLNO $71.20
- MQ $5.50
- AVG Volume (30 Days)
- SLNO 390.6K
- MQ 4.3M
- Earning Date
- SLNO 03-05-2025
- MQ 02-26-2025
- Dividend Yield
- SLNO N/A
- MQ N/A
- EPS Growth
- SLNO N/A
- MQ N/A
- EPS
- SLNO N/A
- MQ 0.03
- Revenue
- SLNO N/A
- MQ $490,027,000.00
- Revenue This Year
- SLNO N/A
- MQ N/A
- Revenue Next Year
- SLNO N/A
- MQ $15.46
- P/E Ratio
- SLNO N/A
- MQ $137.05
- Revenue Growth
- SLNO N/A
- MQ N/A
- 52 Week Low
- SLNO $36.61
- MQ $3.37
- 52 Week High
- SLNO $60.92
- MQ $7.36
- Technical
- Relative Strength Index (RSI)
- SLNO 40.51
- MQ 45.67
- Support Level
- SLNO $48.48
- MQ $3.58
- Resistance Level
- SLNO $52.46
- MQ $3.97
- Average True Range (ATR)
- SLNO 2.07
- MQ 0.13
- MACD
- SLNO -0.47
- MQ 0.00
- Stochastic Oscillator
- SLNO 0.94
- MQ 29.11
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.